SNCA and Parkinson disease: In fact, applying the system to human induced pluripotent stem cell (hiPSC)-derived dopaminergic neurons from a Parkinson’s disease (PD) patient with a SNCA triplication resulted in downregulation of both SNCA mRNA and α-Syn protein, mediated by targeted DNA methylation at intron 1 (Kantor et al., 2018).